as Issuer andIndenture • May 25th, 2006 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 25th, 2006 Company Industry Jurisdiction
EXECUTION VERSION Enzon Pharmaceuticals, Inc. 4% Convertible Senior Notes due 2013 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 25th, 2006 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 25th, 2006 Company Industry Jurisdiction